Mesa Laboratories closed at $125.48 on Nov 3, up 2.88%, 11.8% below its 52-week closing high. Volume of 91.5K shares was 0.98× its 20-day average (close to normal).
Split-adjusted performance: -11.8% over one month, +20.8% over six months, +74.5% over one year.
In the quarter ended Jun 30, 2026, revenue was $60.14M, up 1.0% from a year earlier, with a net margin of 4.7%.
Short interest was 390.6K shares at the Oct 15 settlement, down 12.6% from the prior report (7.7% of float, 3.8 days to cover).